Mark Emberton
iris.ucl.ac.uk
0000-0003-4230-0338
UCL School of Management
15 papers found
Refreshing results…
Imaging modalities for characterising T1 renal tumours: A systematic review and meta‐analysis of diagnostic accuracy
Prostate cancer detection and complications of MRI-targeted prostate biopsy using cognitive registration, software-assisted image fusion or in-bore guidance: a systematic review and meta-analysis of comparative studies
Combiner and HyperCombiner networks: Rules to combine multimodality MR images for prostate cancer localisation
Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysis
Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol
Protocol for a MULTI-centre feasibility study to assess the use of99mTc-sestaMIBI SPECT/CT in the diagnosis of kidney tumours (MULTI-MIBI study)
Early detection of cancer
Conventional radical versus focal treatment for localised prostate cancer: a propensity score weighted comparison of 6-year tumour control
Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study
Prostate Imaging Quality (PI-QUAL): A New Quality Control Scoring System for Multiparametric Magnetic Resonance Imaging of the Prostate from the PRECISION trial
Prostate cancer visibility on multiparametric magnetic resonance imaging: high Gleason grade and increased tumour volume are not the only important histopathological features
Exploring Patient Views and Acceptance of Multiparametric Magnetic Resonance Imaging for the Investigation of Suspected Prostate Cancer (the PACT Study): A Mixed-Methods Study Protocol
Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study
Genetic correlates of prostate cancer visibility (and invisibility) on multiparametric magnetic resonance imaging: it's time to take stock
Multiparametric MRI for prostate cancer diagnosis: current status and future directions
Missing publications? Search for publications with a matching author name.